Results 241 to 250 of about 348,699 (383)

Intrapartum Antibiotic Prophylaxis and Child Health Outcomes: A Systematic Review and Meta‐Analysis of Observational Studies

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background With increasing use of intrapartum antibiotic prophylaxis (IAP) for the prevention of early‐onset Group B streptococcus (GBS) infections, there is concern about its long‐term consequences on child health. Objectives To synthesise the evidence of IAP exposure on autoimmune‐related diseases, obesity in childhood and microbial ...
Maedeh Moradi   +3 more
wiley   +1 more source

A CASE OF ATOPIC DERMATITIS WITH PRURIGO TREATED BY EICOSAPENTAENOIC ACID

open access: bronze, 1989
Akiyoshi Sasamoto   +5 more
openalex   +2 more sources

Baricitinib Augments Lonafarnib Therapy to Preserve Colonic Homeostasis and Microbial Balance in a Mouse Model of Progeria

open access: yesAging Cell, EarlyView.
Combined baricitinib and lonafarnib treatment improved colonic pathology in LmnaG609G/G609G progeria mice by reducing progerin, maintaining epithelial regeneration, mitigating inflammation and senescence, and preserving microbiome composition. ABSTRACT Hutchinson‐Gilford Progeria Syndrome (HGPS) is a fatal genetic disorder caused by progerin, a mutant ...
Moritz Schroll   +4 more
wiley   +1 more source

Innovative microbial strategies in atopic dermatitis. [PDF]

open access: yesFront Immunol
Ma J   +13 more
europepmc   +1 more source

Thymopentin therapy reduces the clinical severity of atopic dermatitis

open access: bronze, 1990
Donald Y.M. Leung   +9 more
openalex   +1 more source

Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise

open access: yesAustralasian Journal of Dermatology, EarlyView.
ABSTRACT Background/Objectives Janus kinase inhibitors (JAKis) have been approved by the Therapeutic Goods Administration for severe alopecia areata (AA) in Australia. However, access is limited as JAKis are not currently subsidised on the Pharmaceutical Benefits Scheme for this indication. This study aimed to establish expert consensus on criteria for
Meryl Thomas   +23 more
wiley   +1 more source

Allergenicity of peanut and soybean extracts altered by chemical or thermal denaturation in patients with atopic dermatitis and positive food challenges

open access: bronze, 1992
A. Wesley Burks   +5 more
openalex   +1 more source

Retrospective Review on Safety and Efficacy of Combination Biologic Therapy for Psoriasis

open access: yesAustralasian Journal of Dermatology, EarlyView.
ABSTRACT Background There is limited data on the use of dual or combination biologic therapy in dermatological patients, particularly in psoriasis or with other coexisting dermatological conditions. However, this may be necessary for a small proportion of patients.
Nicole Kah Mun Yoong   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy